nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—HTR2A—Alzheimer's disease	0.363	1	CbGaD
Acepromazine—HTR2A—Donepezil—Alzheimer's disease	0.254	0.556	CbGbCtD
Acepromazine—DRD2—Memantine—Alzheimer's disease	0.203	0.444	CbGbCtD
Acepromazine—HTR2A—choroid plexus—Alzheimer's disease	0.011	0.131	CbGeAlD
Acepromazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00824	0.0987	CbGeAlD
Acepromazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00677	0.0811	CbGeAlD
Acepromazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00552	0.0661	CbGeAlD
Acepromazine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00539	0.0645	CbGeAlD
Acepromazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00487	0.0583	CbGeAlD
Acepromazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00321	0.0384	CbGeAlD
Acepromazine—DRD1—forebrain—Alzheimer's disease	0.00215	0.0258	CbGeAlD
Acepromazine—DRD1—telencephalon—Alzheimer's disease	0.00198	0.0237	CbGeAlD
Acepromazine—SLC22A1—forebrain—Alzheimer's disease	0.0017	0.0204	CbGeAlD
Acepromazine—HTR2A—blood vessel—Alzheimer's disease	0.00159	0.019	CbGeAlD
Acepromazine—SLC22A1—telencephalon—Alzheimer's disease	0.00157	0.0188	CbGeAlD
Acepromazine—HTR1A—forebrain—Alzheimer's disease	0.00141	0.0168	CbGeAlD
Acepromazine—ADRA1A—forebrain—Alzheimer's disease	0.0013	0.0155	CbGeAlD
Acepromazine—HTR1A—telencephalon—Alzheimer's disease	0.00129	0.0155	CbGeAlD
Acepromazine—DRD2—forebrain—Alzheimer's disease	0.00127	0.0152	CbGeAlD
Acepromazine—ADRA1B—nervous system—Alzheimer's disease	0.00125	0.015	CbGeAlD
Acepromazine—ADRA1B—central nervous system—Alzheimer's disease	0.00121	0.0144	CbGeAlD
Acepromazine—ADRA1A—telencephalon—Alzheimer's disease	0.00119	0.0143	CbGeAlD
Acepromazine—DRD2—telencephalon—Alzheimer's disease	0.00117	0.014	CbGeAlD
Acepromazine—DRD1—nervous system—Alzheimer's disease	0.00117	0.014	CbGeAlD
Acepromazine—DRD1—central nervous system—Alzheimer's disease	0.00112	0.0135	CbGeAlD
Acepromazine—Olopatadine—S100B—Alzheimer's disease	0.000987	0.121	CrCbGaD
Acepromazine—ADRA1B—brain—Alzheimer's disease	0.000958	0.0115	CbGeAlD
Acepromazine—HTR2A—embryo—Alzheimer's disease	0.000948	0.0114	CbGeAlD
Acepromazine—SLC22A1—nervous system—Alzheimer's disease	0.000925	0.0111	CbGeAlD
Acepromazine—DRD1—brain—Alzheimer's disease	0.000893	0.0107	CbGeAlD
Acepromazine—SLC22A1—central nervous system—Alzheimer's disease	0.00089	0.0107	CbGeAlD
Acepromazine—HTR2A—forebrain—Alzheimer's disease	0.000839	0.01	CbGeAlD
Acepromazine—HTR2A—telencephalon—Alzheimer's disease	0.000771	0.00923	CbGeAlD
Acepromazine—HTR1A—nervous system—Alzheimer's disease	0.000764	0.00914	CbGeAlD
Acepromazine—HTR1A—central nervous system—Alzheimer's disease	0.000735	0.0088	CbGeAlD
Acepromazine—HTR1A—cerebellum—Alzheimer's disease	0.000719	0.00861	CbGeAlD
Acepromazine—SLC22A1—brain—Alzheimer's disease	0.000707	0.00846	CbGeAlD
Acepromazine—ADRA1A—nervous system—Alzheimer's disease	0.000704	0.00843	CbGeAlD
Acepromazine—DRD2—nervous system—Alzheimer's disease	0.00069	0.00826	CbGeAlD
Acepromazine—ADRA1A—central nervous system—Alzheimer's disease	0.000678	0.00812	CbGeAlD
Acepromazine—ALB—brain—Alzheimer's disease	0.000677	0.0081	CbGeAlD
Acepromazine—DRD2—central nervous system—Alzheimer's disease	0.000664	0.00796	CbGeAlD
Acepromazine—ADRA1A—cerebellum—Alzheimer's disease	0.000663	0.00793	CbGeAlD
Acepromazine—DRD2—cerebellum—Alzheimer's disease	0.000649	0.00778	CbGeAlD
Acepromazine—HTR1A—brain—Alzheimer's disease	0.000584	0.00699	CbGeAlD
Acepromazine—Dimetacrine—ACHE—Alzheimer's disease	0.000571	0.0701	CrCbGaD
Acepromazine—ADRA1A—brain—Alzheimer's disease	0.000538	0.00644	CbGeAlD
Acepromazine—DRD2—brain—Alzheimer's disease	0.000528	0.00632	CbGeAlD
Acepromazine—HTR2A—nervous system—Alzheimer's disease	0.000455	0.00545	CbGeAlD
Acepromazine—HTR2A—central nervous system—Alzheimer's disease	0.000438	0.00525	CbGeAlD
Acepromazine—HTR2A—cerebellum—Alzheimer's disease	0.000428	0.00513	CbGeAlD
Acepromazine—HTR2A—brain—Alzheimer's disease	0.000348	0.00417	CbGeAlD
Acepromazine—Thiothixene—HTR6—Alzheimer's disease	0.000297	0.0364	CrCbGaD
Acepromazine—Mesoridazine—HTR6—Alzheimer's disease	0.000293	0.0359	CrCbGaD
Acepromazine—Fluphenazine—CALM1—Alzheimer's disease	0.000284	0.0349	CrCbGaD
Acepromazine—Fluphenazine—HTR6—Alzheimer's disease	0.000256	0.0315	CrCbGaD
Acepromazine—Clomipramine—HTR6—Alzheimer's disease	0.000234	0.0288	CrCbGaD
Acepromazine—Chlorprothixene—HTR6—Alzheimer's disease	0.000233	0.0287	CrCbGaD
Acepromazine—Promethazine—CALM1—Alzheimer's disease	0.00023	0.0283	CrCbGaD
Acepromazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000227	0.0279	CrCbGaD
Acepromazine—Perphenazine—CALM1—Alzheimer's disease	0.000225	0.0276	CrCbGaD
Acepromazine—Thioridazine—HTR6—Alzheimer's disease	0.000221	0.0271	CrCbGaD
Acepromazine—Trifluoperazine—HTR6—Alzheimer's disease	0.000205	0.0252	CrCbGaD
Acepromazine—Perphenazine—HTR6—Alzheimer's disease	0.000203	0.0249	CrCbGaD
Acepromazine—Ethopropazine—BCHE—Alzheimer's disease	0.0002	0.0245	CrCbGaD
Acepromazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000178	0.0219	CrCbGaD
Acepromazine—Triflupromazine—BCHE—Alzheimer's disease	0.000163	0.0201	CrCbGaD
Acepromazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000161	0.0197	CrCbGaD
Acepromazine—Imipramine—HTR6—Alzheimer's disease	0.00016	0.0196	CrCbGaD
Acepromazine—Cyamemazine—HTR2A—Alzheimer's disease	0.000141	0.0173	CrCbGaD
Acepromazine—Mequitazine—CYP2D6—Alzheimer's disease	0.000112	0.0138	CrCbGaD
Acepromazine—Diltiazem—CYP2D6—Alzheimer's disease	0.000101	0.0124	CrCbGaD
Acepromazine—Clomipramine—SLC6A4—Alzheimer's disease	8.97e-05	0.011	CrCbGaD
Acepromazine—Thioproperazine—HTR2A—Alzheimer's disease	8.87e-05	0.0109	CrCbGaD
Acepromazine—Thiothixene—HTR2A—Alzheimer's disease	8.73e-05	0.0107	CrCbGaD
Acepromazine—Pipotiazine—HTR2A—Alzheimer's disease	8.73e-05	0.0107	CrCbGaD
Acepromazine—Mesoridazine—HTR2A—Alzheimer's disease	8.61e-05	0.0106	CrCbGaD
Acepromazine—Trimipramine—SLC6A4—Alzheimer's disease	8.26e-05	0.0101	CrCbGaD
Acepromazine—Thiothixene—CYP2D6—Alzheimer's disease	7.98e-05	0.0098	CrCbGaD
Acepromazine—Pipotiazine—CYP2D6—Alzheimer's disease	7.98e-05	0.0098	CrCbGaD
Acepromazine—Chlorpromazine—BCHE—Alzheimer's disease	7.89e-05	0.00968	CrCbGaD
Acepromazine—Mesoridazine—CYP2D6—Alzheimer's disease	7.88e-05	0.00967	CrCbGaD
Acepromazine—Prochlorperazine—CYP2D6—Alzheimer's disease	7.63e-05	0.00936	CrCbGaD
Acepromazine—Fluphenazine—HTR2A—Alzheimer's disease	7.54e-05	0.00926	CrCbGaD
Acepromazine—Propiomazine—HTR2A—Alzheimer's disease	7.25e-05	0.00891	CrCbGaD
Acepromazine—Desipramine—SLC6A4—Alzheimer's disease	7.22e-05	0.00886	CrCbGaD
Acepromazine—Clomipramine—HTR2A—Alzheimer's disease	6.9e-05	0.00847	CrCbGaD
Acepromazine—Fluphenazine—CYP2D6—Alzheimer's disease	6.9e-05	0.00847	CrCbGaD
Acepromazine—Chlorprothixene—HTR2A—Alzheimer's disease	6.87e-05	0.00843	CrCbGaD
Acepromazine—Thioridazine—HTR2A—Alzheimer's disease	6.5e-05	0.00798	CrCbGaD
Acepromazine—Trimipramine—HTR2A—Alzheimer's disease	6.35e-05	0.00779	CrCbGaD
Acepromazine—Clomipramine—CYP2D6—Alzheimer's disease	6.31e-05	0.00774	CrCbGaD
Acepromazine—Methotrimeprazine—HTR2A—Alzheimer's disease	6.2e-05	0.00762	CrCbGaD
Acepromazine—Imipramine—SLC6A4—Alzheimer's disease	6.12e-05	0.00752	CrCbGaD
Acepromazine—Promethazine—HTR2A—Alzheimer's disease	6.11e-05	0.0075	CrCbGaD
Acepromazine—Trifluoperazine—HTR2A—Alzheimer's disease	6.03e-05	0.0074	CrCbGaD
Acepromazine—Perphenazine—HTR2A—Alzheimer's disease	5.96e-05	0.00732	CrCbGaD
Acepromazine—Thioridazine—CYP2D6—Alzheimer's disease	5.94e-05	0.00729	CrCbGaD
Acepromazine—Trimipramine—CYP2D6—Alzheimer's disease	5.8e-05	0.00712	CrCbGaD
Acepromazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	5.67e-05	0.00696	CrCbGaD
Acepromazine—Promethazine—CYP2D6—Alzheimer's disease	5.59e-05	0.00686	CrCbGaD
Acepromazine—Desipramine—HTR2A—Alzheimer's disease	5.55e-05	0.00681	CrCbGaD
Acepromazine—Perphenazine—CYP2D6—Alzheimer's disease	5.45e-05	0.00669	CrCbGaD
Acepromazine—Promazine—HTR2A—Alzheimer's disease	5.38e-05	0.0066	CrCbGaD
Acepromazine—Desipramine—CYP2D6—Alzheimer's disease	5.07e-05	0.00623	CrCbGaD
Acepromazine—Chlorpromazine—HTR2A—Alzheimer's disease	4.73e-05	0.00581	CrCbGaD
Acepromazine—Imipramine—HTR2A—Alzheimer's disease	4.71e-05	0.00578	CrCbGaD
Acepromazine—Chlorpromazine—CYP2D6—Alzheimer's disease	4.33e-05	0.00531	CrCbGaD
Acepromazine—Imipramine—CYP2D6—Alzheimer's disease	4.3e-05	0.00528	CrCbGaD
Acepromazine—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.48e-05	0.000168	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.47e-05	0.000167	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ACHE—Alzheimer's disease	1.46e-05	0.000166	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	1.45e-05	0.000165	CbGpPWpGaD
Acepromazine—ALB—Metabolism—INPP5D—Alzheimer's disease	1.44e-05	0.000164	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	1.44e-05	0.000164	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—LPL—Alzheimer's disease	1.43e-05	0.000163	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	1.43e-05	0.000163	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	1.42e-05	0.000162	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	1.42e-05	0.000162	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MEF2C—Alzheimer's disease	1.42e-05	0.000162	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—NOS3—Alzheimer's disease	1.41e-05	0.000161	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	1.41e-05	0.00016	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	1.4e-05	0.000159	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.4e-05	0.000159	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	1.4e-05	0.000159	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	1.39e-05	0.000159	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PRKCG—Alzheimer's disease	1.39e-05	0.000159	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.37e-05	0.000156	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ENO1—Alzheimer's disease	1.37e-05	0.000156	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS1—Alzheimer's disease	1.37e-05	0.000156	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—LPL—Alzheimer's disease	1.37e-05	0.000155	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NGF—Alzheimer's disease	1.36e-05	0.000154	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP2D6—Alzheimer's disease	1.34e-05	0.000153	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	1.33e-05	0.000151	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	1.33e-05	0.000151	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	1.33e-05	0.000151	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR5—Alzheimer's disease	1.32e-05	0.00015	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	1.32e-05	0.00015	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	1.3e-05	0.000149	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.3e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	1.3e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR2A—Alzheimer's disease	1.29e-05	0.000147	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	1.29e-05	0.000147	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.28e-05	0.000146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	1.28e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Acepromazine—ALB—Metabolism—BCHE—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.27e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.27e-05	0.000144	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	1.27e-05	0.000144	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	1.26e-05	0.000144	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.25e-05	0.000142	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.24e-05	0.000141	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	1.23e-05	0.00014	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	1.23e-05	0.00014	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	1.22e-05	0.000139	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	1.22e-05	0.000139	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.22e-05	0.000139	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	1.21e-05	0.000137	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	1.2e-05	0.000137	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PLCB1—Alzheimer's disease	1.2e-05	0.000137	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—LEP—Alzheimer's disease	1.2e-05	0.000137	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—APOE—Alzheimer's disease	1.2e-05	0.000137	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.2e-05	0.000136	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	1.19e-05	0.000135	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	1.18e-05	0.000134	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.18e-05	0.000134	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	1.17e-05	0.000134	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	1.17e-05	0.000133	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	1.17e-05	0.000133	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ABCA1—Alzheimer's disease	1.16e-05	0.000133	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	1.16e-05	0.000132	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CALM1—Alzheimer's disease	1.15e-05	0.000131	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	1.15e-05	0.000131	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	1.15e-05	0.00013	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APOE—Alzheimer's disease	1.14e-05	0.00013	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	1.14e-05	0.00013	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	1.13e-05	0.000129	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CAV1—Alzheimer's disease	1.13e-05	0.000129	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—F2—Alzheimer's disease	1.13e-05	0.000129	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	1.13e-05	0.000128	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	1.12e-05	0.000128	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.11e-05	0.000126	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.09e-05	0.000124	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	1.08e-05	0.000123	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	1.08e-05	0.000123	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	1.07e-05	0.000122	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	1.06e-05	0.000121	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	1.06e-05	0.00012	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	1.05e-05	0.00012	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	1.05e-05	0.00012	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	1.04e-05	0.000119	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	1.04e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	1.04e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	1.03e-05	0.000118	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.03e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	1.03e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	1.03e-05	0.000118	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	1.03e-05	0.000117	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—INS—Alzheimer's disease	1.03e-05	0.000117	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	1.02e-05	0.000117	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	1.02e-05	0.000116	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—VEGFA—Alzheimer's disease	1.02e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.01e-05	0.000115	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	1.01e-05	0.000115	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	1.01e-05	0.000115	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARGC1A—Alzheimer's disease	1e-05	0.000114	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HMOX1—Alzheimer's disease	9.99e-06	0.000114	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PPARG—Alzheimer's disease	9.97e-06	0.000114	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	9.96e-06	0.000113	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	9.92e-06	0.000113	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	9.87e-06	0.000112	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	9.86e-06	0.000112	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	9.85e-06	0.000112	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	9.83e-06	0.000112	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	9.83e-06	0.000112	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	9.8e-06	0.000112	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—INS—Alzheimer's disease	9.78e-06	0.000111	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	9.75e-06	0.000111	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	9.74e-06	0.000111	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—F2—Alzheimer's disease	9.73e-06	0.000111	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	9.6e-06	0.000109	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.53e-06	0.000108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	9.39e-06	0.000107	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	9.38e-06	0.000107	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TGFB1—Alzheimer's disease	9.36e-06	0.000107	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	9.27e-06	0.000106	CbGpPWpGaD
Acepromazine—ALB—Metabolism—LPL—Alzheimer's disease	9.13e-06	0.000104	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	9.09e-06	0.000104	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.07e-06	0.000103	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	9.06e-06	0.000103	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	9.06e-06	0.000103	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	8.99e-06	0.000102	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	8.98e-06	0.000102	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	8.95e-06	0.000102	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	8.94e-06	0.000102	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	8.92e-06	0.000102	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	8.92e-06	0.000102	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	8.87e-06	0.000101	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	8.83e-06	0.000101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	8.82e-06	0.0001	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	8.76e-06	9.98e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	8.73e-06	9.94e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	8.73e-06	9.94e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	8.68e-06	9.88e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	8.65e-06	9.85e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	8.65e-06	9.85e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—NOS3—Alzheimer's disease	8.58e-06	9.76e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—F2—Alzheimer's disease	8.55e-06	9.73e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	8.53e-06	9.71e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	8.51e-06	9.69e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	8.51e-06	9.69e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	8.44e-06	9.62e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	8.41e-06	9.58e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	8.4e-06	9.56e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	8.36e-06	9.52e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	8.34e-06	9.49e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	8.26e-06	9.41e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	8.23e-06	9.38e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	8.23e-06	9.37e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MTHFR—Alzheimer's disease	8.22e-06	9.37e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	8.12e-06	9.25e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	8.06e-06	9.18e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	7.85e-06	8.94e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	7.84e-06	8.93e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	7.79e-06	8.86e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INS—Alzheimer's disease	7.74e-06	8.82e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	7.73e-06	8.81e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	7.72e-06	8.79e-05	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	7.71e-06	8.77e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—TP53—Alzheimer's disease	7.7e-06	8.77e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CALM1—Alzheimer's disease	7.68e-06	8.75e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	7.66e-06	8.72e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOE—Alzheimer's disease	7.66e-06	8.72e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	7.63e-06	8.69e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	7.62e-06	8.67e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	7.62e-06	8.67e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CAV1—Alzheimer's disease	7.59e-06	8.64e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	7.58e-06	8.64e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	7.56e-06	8.61e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	7.5e-06	8.54e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	7.49e-06	8.53e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	7.49e-06	8.53e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	7.46e-06	8.49e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	7.37e-06	8.39e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	7.36e-06	8.39e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	7.34e-06	8.36e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	7.21e-06	8.22e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	7.02e-06	7.99e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	7e-06	7.97e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	6.79e-06	7.73e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	6.68e-06	7.61e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PPARG—Alzheimer's disease	6.67e-06	7.59e-05	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.63e-06	7.55e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	6.56e-06	7.48e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—INS—Alzheimer's disease	6.54e-06	7.45e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	6.54e-06	7.45e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	6.52e-06	7.43e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—AKT1—Alzheimer's disease	6.5e-06	7.41e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	6.48e-06	7.38e-05	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.31e-06	7.19e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	6.25e-06	7.12e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	6.21e-06	7.07e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	6.03e-06	6.87e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	6.02e-06	6.85e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	5.95e-06	6.77e-05	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.82e-06	6.62e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	5.76e-06	6.56e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	5.75e-06	6.54e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NOS3—Alzheimer's disease	5.74e-06	6.53e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	5.73e-06	6.53e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	5.73e-06	6.52e-05	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.72e-06	6.52e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	5.67e-06	6.46e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	5.63e-06	6.42e-05	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.61e-06	6.38e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	5.57e-06	6.34e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	5.55e-06	6.32e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	5.52e-06	6.28e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.31e-06	6.04e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	5.3e-06	6.03e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	5.28e-06	6.02e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS2—Alzheimer's disease	5.25e-06	5.97e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	5.21e-06	5.94e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	5.2e-06	5.92e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	5.11e-06	5.82e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	5.1e-06	5.81e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	5.09e-06	5.8e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	4.9e-06	5.57e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	4.89e-06	5.57e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	4.87e-06	5.54e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	4.81e-06	5.48e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.71e-06	5.37e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	4.49e-06	5.11e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	4.48e-06	5.1e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	4.42e-06	5.03e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	4.33e-06	4.93e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	4.21e-06	4.79e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	4.13e-06	4.71e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	4.01e-06	4.56e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	3.94e-06	4.49e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	3.85e-06	4.39e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	3.7e-06	4.21e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	3.67e-06	4.18e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	3.64e-06	4.14e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	3.56e-06	4.05e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	3.55e-06	4.05e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	3.39e-06	3.85e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	3.38e-06	3.85e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	3.33e-06	3.79e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	3.26e-06	3.71e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	3.12e-06	3.55e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	3.07e-06	3.5e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	3.01e-06	3.42e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AKT1—Alzheimer's disease	2.64e-06	3e-05	CbGpPWpGaD
